Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030F)
Tissue Engineering and Regeneration Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, by Application, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1698139
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 145¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2030³â±îÁö CAGRÀº 8.35%·Î, ¿¹Ãø ±â°£ Áß ÀλóÀûÀÎ ¼ºÀåÀ» ´Þ¼ºÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¶Á÷°øÇÐ ¹× Àç»ýÀº ÀÎüÀÇ ¼Õ»óµÈ Á¶Á÷À̳ª Áúº´¿¡ °É¸° Àå±â¸¦ º¹±¸Çϰųª ´ëüÇÒ ¼ö ÀÖ´Â »ý¹°ÇÐÀû ´ëü¹°À» °³¹ßÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃá »ý¹° ÀÇÇÐ ¹× °øÇÐ ºÐ¾ßÀÔ´Ï´Ù. ÀÌ ºÐ¾ß´Â Á¤»óÀûÀÎ Á¶Á÷ ±â´ÉÀ» ȸº¹Çϰí, Ä¡À¯¸¦ ÃËÁøÇϸç, ´Ù¾çÇÑ Áúº´À¸·Î °íÅë¹Þ´Â ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Á¶Á÷°øÇÐÀº ¼¼Æ÷, ¹ÙÀÌ¿À¼ÒÀç, »ýÈ­ÇÐÀû ¿äÀÎÀ» °áÇÕÇÏ¿© ±â´ÉÀûÀÌ°í »ì¾ÆÀÖ´Â Á¶Á÷°ú Àå±â¸¦ ¸¸µé¾î³»´Â °úÇаú ½ÇõÀÔ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030
½ÃÀå ±Ô¸ð : 2024³â 145¾ï 7,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 233¾ï 9,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 8.35%
±Þ¼ºÀå ºÎ¹® Á¶Á÷°øÇÐ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

Àå±â À̽ÄÀÇ ³ôÀº ¼ö¿ä

ÁÖ¿ä ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

±æ°í ºñ¿ëÀÌ ¸¹ÀÌ µå´Â °³¹ß ÇÁ·Î¼¼½º

ÁÖ¿ä ½ÃÀå µ¿Çâ

¸ÂÃãÇü ÀÇ·á

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦8Àå ºÏ¹ÌÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ Á¶Á÷°øÇÐ ¹× Àç»ý ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå PESTEL ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

Á¦17Àå Àü·«Àû Á¦¾È

Á¦18Àå Á¶»çȸ»ç ¼Ò°³¡¤¸éÃ¥»çÇ×

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Tissue Engineering and Regeneration Market was valued at USD 14.57 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.35% through 2030. Tissue Engineering and Regeneration are fields of biomedical science and engineering that focus on the development of biological substitutes to repair or replace damaged or diseased tissues and organs in the human body. These fields aim to restore normal tissue function, promote healing, and improve the quality of life for patients suffering from a wide range of medical conditions. Tissue engineering is the science and practice of creating functional and living tissues or organs using a combination of cells, biomaterials, and biochemical factors.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 14.57 Billion
Market Size 2030USD 23.39 Billion
CAGR 2025-20308.35%
Fastest Growing SegmentTissue Engineering
Largest MarketNorth America

Key Market Drivers

High Demand for Organ Transplants

The demand for organ transplants far exceeds the supply of available donor organs. This shortage of organs for transplantation has led to long waiting lists, and many patients may not receive a transplant in time. Tissue engineering offers a potential solution to address this organ shortage by creating lab-grown organs and tissues. Tissue engineering and regenerative medicine techniques involve growing functional organs and tissues in the laboratory using a patient's cells or other biocompatible materials. This approach provides an alternative source of organs for transplantation, reducing the dependence on donor organs. Tissue engineering allows for the creation of personalized organs that can be tailored to individual patients. This reduces the risk of organ rejection and the need for long-term immunosuppressive medications, which are necessary in traditional organ transplantation. Tissue engineering can create organs that are traditionally challenging to obtain from donors, such as vascularized organs, like hearts and kidneys. This expands the range of available organs for transplantation. In January 2023, a research team led by Dr. Hasan Erbil Abaci at Columbia University began developing techniques to create 3D-engineered skin customized for complex body parts. These tailored grafts can be transplanted with minimal suturing, improving surgical efficiency and outcomes.

Key Market Challenges

Long and Expensive Development Process

The development of regenerative therapies begins with extensive research and preclinical testing to understand the safety and efficacy of the proposed treatments. This stage can take many years and involve substantial financial resources. Clinical trials are a critical step in the development process to demonstrate the safety and effectiveness of regenerative therapies in humans. Conducting these trials involves a substantial investment, takes several years, and requires compliance with stringent regulatory requirements. Obtaining regulatory approvals from agencies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) is a lengthy and costly process. Companies must meet rigorous standards and provide comprehensive data to prove the safety and efficacy of their therapies. Transitioning from small-scale laboratory production to large-scale manufacturing can be challenging. Ensuring consistent and cost-effective production of regenerative therapies is a complex task. Maintaining quality control and standardization throughout the manufacturing process is crucial. Deviations can lead to product inconsistency and may pose risks to patient safety. The development of regenerative therapies requires substantial financial resources, including funding for research, clinical trials, manufacturing facilities, and regulatory compliance. Raising this capital can be a barrier to entry for startups and smaller companies. Many regenerative therapies do not successfully make it to market. The high failure rate in clinical trials and the lengthy timelines contribute to the overall cost of development. The long development process can result in market uncertainties. By the time a therapy reaches the market, changes in the competitive landscape or evolving clinical standards can impact its commercial success.

Key Market Trends

Personalized Medicine

Tissue engineering and regenerative medicine aim to create therapies that are customized to each patient's unique needs. This approach can address individual variations in health, genetics, and disease. Induced pluripotent stem cells (iPSCs) are reprogrammed from a patient's own cells and can be used to generate patient-specific tissues and organs. This minimizes the risk of immune rejection and graft-versus-host disease. Advancements in genomics and molecular profiling allow for a detailed analysis of a patient's genetic and molecular characteristics. This information is used to guide treatment decisions and tailor regenerative therapies. iPSCs and patient-derived cells are used to create disease models, enabling researchers to study diseases in a patient-specific context. This is valuable for understanding disease mechanisms and testing potential treatments. Personalized regenerative therapies reduce the risk of immune rejection, as they are based on the patient's own cells. This minimizes the need for immunosuppressive drugs. By understanding a patient's genetic and molecular profile, clinicians can optimize the choice of tissue engineering and regenerative therapies. This ensures that the treatment is more likely to be effective and safe for the individual patient. Personalized medicine allows clinicians to predict a patient's response to specific therapies, helping to select the most appropriate regenerative approach for a better outcome. Personalized medicine places the patient at the center of care, emphasizing tailored treatments that consider the patient's unique biology, preferences, and needs. In some cases, companion diagnostics are used to identify the most suitable regenerative therapy for a patient based on their genetic or molecular profile.

Key Market Players

Report Scope:

In this report, the Global Tissue Engineering and Regeneration Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tissue Engineering and Regeneration Market, By Product:

Tissue Engineering and Regeneration Market, By Application:

Tissue Engineering and Regeneration Market, By region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tissue Engineering and Regeneration Market.

Available Customizations:

Global Tissue Engineering and Regeneration Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Tissue Engineering and Regeneration Market Outlook

6. Asia Pacific Tissue Engineering and Regeneration Market Outlook

7. Europe Tissue Engineering and Regeneration Market Outlook

8. North America Tissue Engineering and Regeneration Market Outlook

9. South America Tissue Engineering and Regeneration Market Outlook

10. Middle East and Africa Tissue Engineering and Regeneration Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Tissue Engineering and Regeneration Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Competitive Landscape

17. Strategic Recommendations

18. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â